We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$310B
AUM Growth
+$31.1B
Cap. Flow
+$9.23B
Cap. Flow %
2.98%
Top 10 Hldgs %
15.99%
Holding
3,632
New
124
Increased
2,654
Reduced
459
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 19.49%
2 Financials 13.78%
3 Healthcare 13.39%
4 Industrials 9.54%
5 Consumer Discretionary 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRML
3351
DELISTED
Tourmaline Bio
TRML
$51.5K ﹤0.01%
5,049
-354
-7% -$5.69K
EMAN
3352
DELISTED
eMagin Corporation
EMAN
$51.2K ﹤0.01%
+60,265
New +$49.6K
ZVRA icon
3353
Zevra Therapeutics
ZVRA
$562M
$51.1K ﹤0.01%
11,139
NXU
3354
DELISTED
Nxu, Inc. Class A Common Stock
NXU
$50.9K ﹤0.01%
+5
New +$167K
AEG icon
3355
Aegon
AEG
$14B
$50.5K ﹤0.01%
+10,027
New +$46.4K
EVLO
3356
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$50.5K ﹤0.01%
1,567
PMCB icon
3357
PharmaCyte Biotech
PMCB
$6.18M
$50.3K ﹤0.01%
+17,219
New +$49.3K
ATIP
3358
DELISTED
ATI Physical Therapy, Inc.
ATIP
$50.1K ﹤0.01%
3,288
-443
-12% -$14.9K
AAIC
3359
DELISTED
Arlington Asset Investment Corp.
AAIC
$50K ﹤0.01%
17,051
KOPN icon
3360
Kopin
KOPN
$652M
$49.8K ﹤0.01%
40,189
TOON icon
3361
Kartoon Studios
TOON
$35.2M
$49.4K ﹤0.01%
10,629
GEG icon
3362
Great Elm Group
GEG
$67.4M
$49.4K ﹤0.01%
+24,464
New +$49K
SPRO icon
3363
Spero Therapeutics
SPRO
$67.7M
$49.4K ﹤0.01%
+28,565
New +$53.3K
ASXC
3364
DELISTED
Asensus Surgical, Inc.
ASXC
$48.6K ﹤0.01%
139,946
NRXP icon
3365
NRX Pharmaceuticals
NRXP
$135M
$48.5K ﹤0.01%
+4,373
New +$44K
ASRV icon
3366
AmeriServ Financial
ASRV
$77.5M
$48.4K ﹤0.01%
+12,324
New +$48.6K
PAYS icon
3367
Paysign
PAYS
$501M
$48.2K ﹤0.01%
18,698
LTRX icon
3368
Lantronix
LTRX
$240M
$48.1K ﹤0.01%
11,128
STTK icon
3369
Shattuck Labs
STTK
$675M
$48K ﹤0.01%
20,881
GAN
3370
DELISTED
GAN Ltd
GAN
$47.2K ﹤0.01%
+31,476
New +$52.9K
ELVN icon
3371
Enliven Therapeutics
ELVN
$3.92B
$47.1K ﹤0.01%
+2,880
New +$46K
STXS icon
3372
Stereotaxis
STXS
$126M
$47K ﹤0.01%
22,696
ASTI icon
3373
Ascent Solar Technologies
ASTI
$28.6M
$46.7K ﹤0.01%
+1
New +$59.9K
STRM
3374
DELISTED
Streamline Health Solutions
STRM
$45.9K ﹤0.01%
1,935
ITI
3375
DELISTED
Iteris, Inc.
ITI
$45.8K ﹤0.01%
14,737

Similar funds

Charles Schwab's Q4 2022 Portfolio in Review

As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
  • Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
  • Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
  • Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
  • Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
  • Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.

Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.